Drugs / Compound Danshen Dropping Pills
Compound Danshen Dropping Pills
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 42 trials | ||||||
| Phase 4 | NCT05000411 | Aug 2021 → Aug 2023 | myocardial infarction | The First Affiliated Hospital with Nanjing Medical University | Unknown | No outcome recorded |
| Phase 4 | NCT06092736 | Dec 2018 → Jun 2027 expected | coronary microvascular disorder | Qilu Hospital of Shandong University | Recruiting | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT05295329 | Apr → Sep 2022 | diabetes mellitus | Ruijin Hospital | Unknown | No outcome recorded |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Compound Danshen Dropping Pills | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06092736 ↗ |
| Known as | CDDP | “Compound Danshen Dropping Pills (CDDP)” NCT05000411 ↗ |
| Known as | Compound Danshen Dripping Pill | “The main drug studied in this study is Compound Danshen Dripping Pill.” NCT06092736 ↗ |
| Known as | Compound Danshen Dripping Pills | “Compound Danshen Dripping Pills (CDDP), a traditional Chinese medicine, exerts a protective effect on microcirculatory disturbance caused by ischemia-reperfusion injury and...” PMID 37656413 ↗ Sep 20231“Compound Danshen Dripping Pills (Compound Danshen Dripping Pills, produced by Tasly Holding Group Co., Ltd.) is a compound traditional Chinese medicine preparation composed of...” NCT06092736 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “Compound Danshen Dripping Pills (CDDP), a traditional Chinese medicine, exerts a protective effect on microcirculatory disturbance caused by ischemia-reperfusion injury and...” PMID 37656413 ↗ Sep 2023 |
| Route | Oral | “taken orally after meals” NCT06092736 ↗ |